Wilko Weichert - Publications

Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology.

Journal: Translational oncology

Published: May 25, 2025

Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 18, 2025

Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data.

Journal: IEEE transactions on medical imaging

Published: March 03, 2025

Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 07, 2024

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Journal: NPJ precision oncology

Published: August 15, 2024

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

Journal: Neoplasia (New York, N.Y.)

Published: July 11, 2024

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.

Journal: German medical science : GMS e-journal

Published: July 02, 2024

Benchmarking whole exome sequencing in the German network for personalized medicine.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 20, 2024

Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.

Journal: The EMBO journal

Published: June 19, 2024

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study.

Journal: Pulmonology

Published: April 13, 2024

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

Journal: JCO precision oncology

Published: March 21, 2024

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Journal: Nature communications

Published: March 16, 2024

Filters

Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology.

Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology.

Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.

Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.

Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data.

Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data.

Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.

Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.

Benchmarking whole exome sequencing in the German network for personalized medicine.

Benchmarking whole exome sequencing in the German network for personalized medicine.

Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.

Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study.

Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study.

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.